Interstitial Cystitis
Fulranumab in patients with interstitial cystitis/bladder pain syndrome: observations from a randomized, double-blind, placebo-controlled study
January 9, 2017
SU-G-IeP1-10: Permeability Evaluation of Interstitial Cystitis by DCE-MRI of the Bladder
January 9, 2017
Interstitial Cystitis-Associated Urinary Metabolites Identified by Mass-Spectrometry Based Metabolomics Analysis
December 28, 2016
Long-term outcomes of intravesical dimethyl sulfoxide/heparin/hydrocortisone therapy for interstitial cystitis/bladder pain syndrome
December 20, 2016
Pathomechanism of Interstitial Cystitis/Bladder Pain Syndrome and Mapping the Heterogeneity of Disease
December 14, 2016
Functional urological disorders: a sensitized defence response in the bladder-gut-brain axis
December 13, 2016
Clinical implications of the microbiome in urinary tract diseases
December 7, 2016
Differential Expression of ROMK and KCNQ1 Potassium Channels in Bladder Urothelium of Patients with Interstitial Cystitis/Painful Bladder Syndrome
November 30, 2016
Contested evidence: a Dutch reimbursement decision taken to court
November 30, 2016
A prospective randomized controlled multicentre trial comparing intravesical DMSO and chondroïtin sulphate 2% for painful bladder syndrome/interstitial cystitis.
November 14, 2016
Uroplakins and their potential applications in urology
October 19, 2016
Anorectal and Pelvic Pain
October 12, 2016
The Early Histological Effects of Intravesical Instillation of Platelet-Rich Plasma in Cystitis Models
October 12, 2016
Intravesical Botulinum Toxin A Injections for Bladder Pain Syndrome/Interstitial Cystitis: A Systematic Review and Meta-Analysis of Controlled Studies
September 28, 2016